Group One Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.8K | Buy |
112,400
+84,900
| +309% | +$33.8K | ﹤0.01% | 5735 |
|
|
2025
Q4 | $11.6K | Sell |
27,500
-75,800
| -73% | -$40.2K | ﹤0.01% | 6727 |
|
|
2025
Q3 | $69.6K | Sell |
103,300
-79,300
| -43% | -$42.8K | ﹤0.01% | 5679 |
|
|
2025
Q2 | $98.8K | Sell |
182,600
-167,200
| -48% | -$99.3K | ﹤0.01% | 4974 |
|
|
2025
Q1 | $229K | Buy |
349,800
+172,300
| +97% | +$182K | ﹤0.01% | 3872 |
|
|
2024
Q4 | $181K | Buy |
177,500
+159,100
| +865% | +$291K | ﹤0.01% | 4013 |
|
|
2024
Q3 | $15.9K | Sell |
18,400
-22,200
| -55% | -$16.3K | ﹤0.01% | 5361 |
|
|
2024
Q2 | $14.5K | Sell |
40,600
-56,800
| -58% | -$30.7K | ﹤0.01% | 5430 |
|
|
2024
Q1 | $65.3K | Buy |
+97,400
| New | +$70.6K | ﹤0.01% | 4492 |
|
|
2023
Q4 | – | Sell |
-61,100
| Closed | -$36.6K | – | 8121 |
|
|
2023
Q3 | $36.6K | Buy |
+61,100
| New | +$65.4K | ﹤0.01% | 5382 |
|
|
2023
Q2 | – | Sell |
-4,600
| Closed | -$8.1K | – | 8157 |
|
|
2023
Q1 | $8.1K | Buy |
4,600
+200
| +5% | +$571 | ﹤0.01% | 6053 |
|
|
2022
Q4 | $13.8K | Sell |
4,400
-12,100
| -73% | -$47K | ﹤0.01% | 5849 |
|
|
2022
Q3 | $81K | Sell |
16,500
-19,400
| -54% | -$99.7K | ﹤0.01% | 4974 |
|
|
2022
Q2 | $149K | Sell |
35,900
-12,500
| -26% | -$54.1K | ﹤0.01% | 4586 |
|
|
2022
Q1 | $281K | Sell |
48,400
-148,600
| -75% | -$884K | ﹤0.01% | 4441 |
|
|
2021
Q4 | $1.48M | Buy |
197,000
+59,500
| +43% | +$517K | ﹤0.01% | 2932 |
|
|
2021
Q3 | $1.24M | Sell |
137,500
-152,300
| -53% | -$1.51M | ﹤0.01% | 3181 |
|
|
2021
Q2 | $3.47M | Buy |
289,800
+76,400
| +36% | +$865K | ﹤0.01% | 2053 |
|
|
2021
Q1 | $2.67M | Buy |
213,400
+12,400
| +6% | +$167K | ﹤0.01% | 2147 |
|
|
2020
Q4 | $3.14M | Buy |
201,000
+21,700
| +12% | +$254K | 0.01% | 1666 |
|
|
2020
Q3 | $1.69M | Sell |
179,300
-155,400
| -46% | -$1.68M | 0.01% | 1751 |
|
|
2020
Q2 | $3M | Buy |
334,700
+172,000
| +106% | +$1.6M | 0.01% | 1176 |
|
|
2020
Q1 | $1.04M | Sell |
162,700
-291,300
| -64% | -$2.16M | 0.01% | 1492 |
|
|
2019
Q4 | $3.8M | Buy |
454,000
+176,400
| +64% | +$1.62M | 0.03% | 855 |
|
|
2019
Q3 | $2.51M | Sell |
277,600
-69,000
| -20% | -$774K | 0.02% | 1037 |
|
|
2019
Q2 | $3.73M | Buy |
346,600
+78,900
| +29% | +$839K | 0.03% | 688 |
|
|
2019
Q1 | $2.55M | Sell |
267,700
-71,400
| -21% | -$729K | 0.03% | 768 |
|
|
2018
Q4 | $3.89M | Buy |
339,100
+93,400
| +38% | +$1.16M | 0.03% | 630 |
|
|
2018
Q3 | $4.17M | Buy |
245,700
+40,400
| +20% | +$614K | 0.03% | 680 |
|
|
2018
Q2 | $2.92M | Buy |
205,300
+136,100
| +197% | +$2.26M | 0.02% | 858 |
|
|
2018
Q1 | $1.31M | Sell |
69,200
-42,000
| -38% | -$898K | 0.01% | 1303 |
|
|
2017
Q4 | $1.82M | Sell |
111,200
-7,700
| -6% | -$115K | 0.01% | 1246 |
|
|
2017
Q3 | $1.78M | Sell |
118,900
-60,500
| -34% | -$669K | 0.02% | 1127 |
|
|
2017
Q2 | $1.58M | Buy |
179,400
+103,500
| +136% | +$664K | 0.02% | 1115 |
|
|
2017
Q1 | $395K | Buy |
75,900
+1,900
| +3% | +$7.62K | ﹤0.01% | 2014 |
|
|
2016
Q4 | $226K | Sell |
74,000
-64,200
| -46% | -$234K | ﹤0.01% | 2337 |
|
|
2016
Q3 | $640K | Sell |
138,200
-16,700
| -11% | -$84.9K | 0.01% | 1627 |
|
|
2016
Q2 | $897K | Buy |
154,900
+41,100
| +36% | +$262K | 0.01% | 1328 |
|
|
2016
Q1 | $688K | Sell |
113,800
-78,100
| -41% | -$469K | 0.01% | 1461 |
|
|
2015
Q4 | $1.75M | Sell |
191,900
-86,700
| -31% | -$668K | 0.02% | 945 |
|
|
2015
Q3 | $1.57M | Buy |
278,600
+31,500
| +13% | +$260K | 0.02% | 940 |
|
|
2015
Q2 | $2.74M | Buy |
247,100
+57,100
| +30% | +$736K | 0.04% | 572 |
|
|
2015
Q1 | $2.98M | Sell |
190,000
-65,300
| -26% | -$1.01M | 0.05% | 456 |
|
|
2014
Q4 | $3.88M | Buy |
255,300
+54,700
| +27% | +$664K | 0.06% | 379 |
|
|
2014
Q3 | $2.16M | Buy |
200,600
+37,600
| +23% | +$491K | 0.03% | 640 |
|
|
2014
Q2 | $2.49M | Sell |
163,000
-215,900
| -57% | -$3.11M | 0.04% | 579 |
|
|
2014
Q1 | $6.85M | Buy |
378,900
+282,900
| +295% | +$5.45M | 0.12% | 153 |
|
|
2013
Q4 | $1.33M | Sell |
96,000
-47,600
| -33% | -$548K | 0.02% | 913 |
|
|
2013
Q3 | $1.5M | Buy |
143,600
+91,500
| +176% | +$909K | 0.03% | 728 |
|
|
2013
Q2 | $407K | Buy |
+52,100
| New | +$455K | 0.01% | 1520 |
|
Other funds holding SGMO
AC
VCM
VFT
Group One Trading's SGMO Position: Q1 2026 in Review
Group One Trading reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 32% in Q1 2026, selling an estimated $63.6K and leaving 340,305 shares worth $84K. The position accounts for ﹤0.01% of the portfolio, ranked #4880.
Group One Trading first reported a position in SGMO in Q2 2013 and has held it in 50 quarters since. The position peaked at $4.35M in Q4 2020. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.
- Group One Trading held 340,305 shares of SANGAMO THERAPEUTICS INC worth $84K as of Q1 2026.
- Group One Trading sold 159,874 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $63.6K.
- SANGAMO THERAPEUTICS INC made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4880 holding.
- Group One Trading first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 50 quarters since.
- Group One Trading's SANGAMO THERAPEUTICS INC position peaked at $4.35M in Q4 2020.
- 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.